ID

18932

Description

A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00072670

Lien

https://clinicaltrials.gov/show/NCT00072670

Mots-clés

Versions (1)
  1. 24/11/2016 24/11/2016 -
Téléchargé le

24 novembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT00072670

Anglais

Eligibility Prostate Cancer NCT00072670

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
radiographically documented metastatic disease
Description

Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0027627
surgical or chemical castration
Description

Male Castration | Chemical male castration

Type de données

boolean

Alias
UMLS CUI [1]
C0007347
UMLS CUI [2]
C0455189
prostate-specific antigen greater than or equal to (>=) 5 nanogram per milliliter (ng/ml)
Description

Prostate specific antigen measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201544
eastern cooperative oncology group performance status of 0, 1, or 2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
androgen independent disease
Description

androgen independent prostate cancer

Type de données

boolean

Alias
UMLS CUI [1]
C1654637
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with chemotherapy or radiation therapy that was terminated at least 4 weeks before study entry
Description

Chemotherapy Discontinued | Therapeutic radiology procedure Discontinued

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C1444662
treatment with extensive external beam radiation therapy or radionuclide therapy within 6 weeks of study entry (palliative radiation involving less than 20 percent of bone marrow reserves must have been completed at least 4 weeks before study entry)
Description

External Beam Radiation Therapy Extensive | Radionuclide therapy Extensive | Palliative Radiation Therapy Complete | Palliative Radiation Therapy Involving Bone Marrow Mature Neutrophils Percentage

Type de données

boolean

Alias
UMLS CUI [1,1]
C1517033
UMLS CUI [1,2]
C0205231
UMLS CUI [2,1]
C0203608
UMLS CUI [2,2]
C0205231
UMLS CUI [3,1]
C3898008
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C3898008
UMLS CUI [4,2]
C1314939
UMLS CUI [4,3]
C0005953
UMLS CUI [4,4]
C1708947
UMLS CUI [4,5]
C0439165
participant not employing adequate contraception
Description

Contraceptive methods Adequate Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0205411
UMLS CUI [1,3]
C0332268
other serious illness or medical conditions as : uncontrolled congestive heart failure or history of myocardial infection or active angina pectoris within six months preceding registration; active infectious process; chronic active liver disease, including chronic hepatitis b, chronic hepatitis c, or cirrhosis
Description

Illness Serious | Medical condition | Congestive heart failure Uncontrolled | Myocardial Infarction | Angina Pectoris | INFECTIOUS PROCESS | Chronic liver disease | Hepatitis B, Chronic | Hepatitis C, Chronic | Liver Cirrhosis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C3843040
UMLS CUI [3,1]
C0018802
UMLS CUI [3,2]
C0205318
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0002962
UMLS CUI [6]
C0745283
UMLS CUI [7]
C0341439
UMLS CUI [8]
C0524909
UMLS CUI [9]
C0524910
UMLS CUI [10]
C0023890
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT00072670

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Neoplasm Metastasis
Item
radiographically documented metastatic disease
boolean
C0027627 (UMLS CUI [1])
Male Castration | Chemical male castration
Item
surgical or chemical castration
boolean
C0007347 (UMLS CUI [1])
C0455189 (UMLS CUI [2])
Prostate specific antigen measurement
Item
prostate-specific antigen greater than or equal to (>=) 5 nanogram per milliliter (ng/ml)
boolean
C0201544 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
androgen independent prostate cancer
Item
androgen independent disease
boolean
C1654637 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Discontinued | Therapeutic radiology procedure Discontinued
Item
treatment with chemotherapy or radiation therapy that was terminated at least 4 weeks before study entry
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
External Beam Radiation Therapy Extensive | Radionuclide therapy Extensive | Palliative Radiation Therapy Complete | Palliative Radiation Therapy Involving Bone Marrow Mature Neutrophils Percentage
Item
treatment with extensive external beam radiation therapy or radionuclide therapy within 6 weeks of study entry (palliative radiation involving less than 20 percent of bone marrow reserves must have been completed at least 4 weeks before study entry)
boolean
C1517033 (UMLS CUI [1,1])
C0205231 (UMLS CUI [1,2])
C0203608 (UMLS CUI [2,1])
C0205231 (UMLS CUI [2,2])
C3898008 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C3898008 (UMLS CUI [4,1])
C1314939 (UMLS CUI [4,2])
C0005953 (UMLS CUI [4,3])
C1708947 (UMLS CUI [4,4])
C0439165 (UMLS CUI [4,5])
Contraceptive methods Adequate Lacking
Item
participant not employing adequate contraception
boolean
C0700589 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Illness Serious | Medical condition | Congestive heart failure Uncontrolled | Myocardial Infarction | Angina Pectoris | INFECTIOUS PROCESS | Chronic liver disease | Hepatitis B, Chronic | Hepatitis C, Chronic | Liver Cirrhosis
Item
other serious illness or medical conditions as : uncontrolled congestive heart failure or history of myocardial infection or active angina pectoris within six months preceding registration; active infectious process; chronic active liver disease, including chronic hepatitis b, chronic hepatitis c, or cirrhosis
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2])
C0018802 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0002962 (UMLS CUI [5])
C0745283 (UMLS CUI [6])
C0341439 (UMLS CUI [7])
C0524909 (UMLS CUI [8])
C0524910 (UMLS CUI [9])
C0023890 (UMLS CUI [10])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial